Reversible pontine ischemia caused by acetazolamide challenge

American Journal of Neuroradiology

Volumn 18, Issue 9, 1997, Pages 1782-1784

  Komiyama, Masaki ^a   Nishikawa, Misao ^a   Yasui, Toshihiro ^a   Sakamoto, Hiroaki ^a  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Brain, ischemia; Cerebral blood flow; Latrogenic disease or disorder

Indexed keywords

ACETAZOLAMIDE;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN SCINTISCANNING; CASE REPORT; DRUG SAFETY; FUNCTIONAL ASSESSMENT; HEADACHE; HUMAN; IMAGE ANALYSIS; MALE; NEUROLOGIC DISEASE; OCCLUSIVE CEREBROVASCULAR DISEASE;

ACETAZOLAMIDE; BRAIN ISCHEMIA; CARBONIC ANHYDRASE INHIBITORS; DIAGNOSTIC IMAGING; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PONS; VERTEBROBASILAR INSUFFICIENCY;

EID: 0031546006     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Posner JB, Plum F. The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy. J Clin Invest 1960;39: 1246-1258
2. Ehrenreich DL, Burns RA, Alman RW, Fazekas JF. Influence of acetazolamide on cerebral blood flow. Arch Neurol 1961;5:125-130
3. Rowe TO. Acetazolamide delirium. Am J Psychiatry 1977;134: 587-588
4. Vorstrup S, Brun B, Lassen NA. Evaluation of the cerebral vasodilatory capacity by the acetazolamide test before EC-IC bypass surgery in patients with occlusion of the internal carotid artery. Stroke 1986;17:1291-1298
5. Hojer-Pedersen E. Effect of acetazolamide on cerebral blood flow in subacute and chronic cerebrovascular disease. Stroke 1987;18: 887-891
6. Sullivan HG, Kingsbury TB, Morgan ME, et al. The rCBF response to Diamox in normal subjects and cerebrovascular disease patients. J Neurosurg 1987;67:525-534
7. Chollet F, Celsis P, Clanet M, Guiraud-Chaumeil B, Rascol A, Marc-Vergnes JP. SPECT study of cerebral blood flow reactivity after acetazolamide in patients with transient ischemic attacks. Stroke 1989;20:458-464
8. Piepgras A, Schmiedek P, Leinsinger G, Harberl RL, Kirsch CM, Einhäupl KM. A simple test to assess cerebrovascular reserve capacity using transcranial Doppler sonography and acetazolamide. Stroke 1990;21:1306-1311
9. Burt RW, Witt RM, Cikrit DF, Reddy RV. Carotid artery disease: evaluation with acetazolamide-enhanced Tc-99m HMPAO SPECT. Radiology 1992;182:461-466
10. Matsuda H, Tsuji S, Shuke N, Sumiya H, Tonami N, Hisada K. Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylprophylene amine oxime. Eur J Nucl Med 1993;20:391-401
11. Heuser D, Astrup J, Lassen NA, Betz E. Brain carbonic acid acidosis after acetazolamide. Acta Physiol Scand 1975;93:385-390
12. Frankel HM, Garcia E, Malik F, Weiss JK, Weiss HR. Effect of acetazolamide on cerebral blood flow and capillary patency. J Appl Physiol 1992;73:1756-1761
13. Hauge A, Nicolaysen G, Thoresen M. Acute effects of acetazolamide on cerebral blood flow in man. Acta Physiol Scand 1983;117:233-239
14. Vorstrup S, Henriksen L, Paulson OB. Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. J Clin Invest 1984;74:1634-1639
15. Maisey DN, Brown RD. Acetazolamide and symptomatic metabolic acidosis in mild renal failure. Br Med J 1981;283:1527-1528
16. Roy LF, Dufresne LR, Legault L, Long H, Morin C. Acetazolamide in hemodialysis patients: a rational use after ocular surgery. Am J Kidney Dis 1992;20:650-652
17. Sweeney KR, Chapron DJ, Brandt JL, Gomolin IH, Feig PU, Kramer PA. Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanation. Clin Pharmacol Ther 1986;40:518-524
18. Epstein DL, Grant WM. Carbonic anhydrase inhibitor side effects. Serum chemical analysis. Arch Ophthalmol 1977; 95: 1378-1382.